1. Zhong, Anyuan, Chen, Ting, Xing, Yufei, Pan, Xue, Shi, Minhua. 2021. FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer. In Frontiers in immunology, 12, 758648. doi:10.3389/fimmu.2021.758648. https://pubmed.ncbi.nlm.nih.gov/34745134/
2. Fu, Jinxing, Guo, Qing, Feng, Yuan, Cheng, Peng, Wu, Anhua. 2022. Dual role of fucosidase in cancers and its clinical potential. In Journal of Cancer, 13, 3121-3132. doi:10.7150/jca.75840. https://pubmed.ncbi.nlm.nih.gov/36046653/
3. Liu, Qun, Dong, Hui-Ting, Zhao, Tingting, Jin, Feng, Xing, Peng. 2022. Cancer-associated adipocytes release FUCA2 to promote aggressiveness in TNBC. In Endocrine-related cancer, 29, 139-149. doi:10.1530/ERC-21-0243. https://pubmed.ncbi.nlm.nih.gov/34935631/
4. Hu, Yuanhui, Tang, Dongling, Zhang, Pingan. 2023. Prognostic and immunological role of alpha-L-fucosidase 2 (FUCA2) in hepatocellular carcinoma. In Translational cancer research, 12, 257-272. doi:10.21037/tcr-22-1850. https://pubmed.ncbi.nlm.nih.gov/36915579/
5. Duarte, Julio D, Desai, Ankit A, Sysol, Justin R, Gordeuk, Victor R, Machado, Roberto F. 2016. Genome-Wide Analysis Identifies IL-18 and FUCA2 as Novel Genes Associated with Diastolic Function in African Americans with Sickle Cell Disease. In PloS one, 11, e0163013. doi:10.1371/journal.pone.0163013. https://pubmed.ncbi.nlm.nih.gov/27636371/
6. Peng, Yuanyuan, Yang, Xingyu, Liu, Yafeng, Wu, Jing, Hu, Dong. 2024. The regulation of the cell cycle and epithelial-mesenchymal transition through FUCA2/GGH signaling promotes the progression of lung adenocarcinoma. In Gene, 939, 149183. doi:10.1016/j.gene.2024.149183. https://pubmed.ncbi.nlm.nih.gov/39710011/
7. Li, Yu, Deng, Yaju, He, Jie. . Monocyte-related gene biomarkers for latent and active tuberculosis. In Bioengineered, 12, 10799-10811. doi:10.1080/21655979.2021.2003931. https://pubmed.ncbi.nlm.nih.gov/34751089/
智鼠故事 
